Clinical trial
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
NCT01078636
Drugs and interventions used in this trial
0 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No interventions are currently published for this study in CureCurrent. View the original registry record below.
Study at a glance
Registry-backedAlzheimer's Disease Neuroimaging Initiative Grand Opportunity
Design: OBSERVATIONAL · Status: COMPLETED · Phase: Not specified
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Mild Cognitive Impairmentunresolved
Alzheimer's Diseaseverified · MONDO: Alzheimer disease
Interventions
Sponsors & collaborators
Alzheimer's Disease Cooperative Study (ADCS)lead sponsor
National Institute on Aging (NIA)collaborator
Mapped research locations
New YorkNew York, United States3BostonMassachusetts, United States2ChicagoIllinois, United States2Los AngelesCalifornia, United States2Washington D.C.District of Columbia, United States2ProvidenceRhode Island, United States2IrvineCalifornia, United States2HoustonTexas, United States1PhiladelphiaPennsylvania, United States1DallasTexas, United States1BaltimoreMaryland, United States1St LouisMissouri, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01078636 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.